Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma
Authors:
- Jie WilleyJWJie Willey
- Richard L. TheriaultRTRichard L. Theriault
- James L. MurrayJMJames L. Murray
- Robert BastRobert Bast
Open Access
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.Journal of Clinical Oncology, 1993
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI: Journal of the National Cancer Institute, 1991
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI: Journal of the National Cancer Institute, 1990
- Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.Journal of Clinical Oncology, 1989
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989
- Five-day continuous-infusion vinblastine in the treatment of breast cancerCancer, 1985
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982
- Phase I study of protracted venous infusion of 5-fluorouracilCancer, 1981
- A phase III study comparing the clinical utility of four regimens of 5-Fluorouracil.A preliminary reportCancer, 1977
- Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinomaCancer, 1975